News • Politics

EIBIR launches its Strategic Research Agenda for Biomedical Imaging

The European Institute for Biomedical Imaging Research (EIBIR) has published its Strategic Research Agenda (SRA) for Biomedical Imaging. The agenda identifies current challenges and needs in healthcare, illustrating how biomedical imaging and derived data can help to address these challenges, in order to stimulate dedicated research funding efforts and mechanisms.

Photo

The SRA was developed in collaboration with EIBIR`s shareholders representing scientific societies related to biomedical imaging, as well as EIBIR's Scientific Advisory Board. It identifies and describes five main challenges facing biomedical imaging today, and addresses in detail how these challenges can be overcome.

In particular, the agenda addresses the current paradigm shift in medicine and healthcare, which has moved from a reactive to proactive approaches and solutions by providing predictive, preventive, and personalised medical solutions for the individual patient. It highlights the growing impact of personalised medicine on patients and its ability to address the challenges of ineffective treatment and rising healthcare costs. The SRA also focusses on the growing importance of big data, artificial intelligence, and innovative imaging technologies, emphasising biomedical imaging’s role as a forerunner in the digital transformation of healthcare and as a leading discipline in the adoption of new innovative solutions like deep learning and artificial intelligence.

EIBIR is a nonprofit organisation founded by the European Society of Radiology and supports researchers and industry partners in the preparation and coordination of biomedical imaging research projects throughout Europe. EIBIR comprises a large and diverse landscape of more than 130 network members (universities, hospitals and research organisations) and is committed to supporting the development of biomedical imaging technologies and to the disseminating of knowledge with the ultimate goal of improving the diagnosis, treatment, and prevention of disease.

Through its Strategic Research Agenda for Biomedical Imaging, EIBIR hopes to stimulate and direct funding efforts towards research projects and developments which will address some of the most important challenges facing healthcare in Europe and the rest of the world.

You can read the Strategic Research Agenda for Biomdical Imaging here.

Source: ESR Press Office

08.10.2018

Read all latest stories

Related articles

Photo

News • Tissue tension measurement

New ultrasound method could lead to easier disease diagnosis

A new ultrasound method that can measure the level of tension in human tissue for the first time - a key indicator of disease - has been developed by researchers from the University of Sheffield.

Photo

News • Augmented reality system

AR-powered free-hand, real-time needle guidance for prostate cancer diagnosis

Researchers demonstrate a HoloLens AR system that enables accurate, flexible needle guidance for transperineal prostate interventions such as biopsy, focal laser ablation, and brachytherapy

Photo

Article • Renal carcinoma differentiation

SPECT/CT improves diagnosis of indeterminate kidney tumours

99mTc-Sestamibi SPECT/CT can aid in the diagnosis of solid renal lesions, especially in cases where contrast enhanced CT findings are inconclusive, according to researchers from the Mallinckrodt…

Related products

SuperSonic Mach 30

Ultrasound

Hologic · SuperSonic Mach 30

Hologic, Inc.
2-part PMMA CT-Phantom

Testing Devices

IBA Dosimetry · 2-part PMMA CT-Phantom

IBA Dosimetry GmbH
3-part PMMA CT-Phantom

Testing Devices

IBA Dosimetry · 3-part PMMA CT-Phantom

IBA Dosimetry GmbH
Accutron CT

Injectors

Medtron AG · Accutron CT

MEDTRON AG
Subscribe to Newsletter